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Review Article
Clinical Application of Ceramics in Anterior
Cervical Discectomy and Fusion:
A Review and Update
Shayan Abdollah Zadegan, MD1, Aidin Abedi, MD1,
Seyed Behnam Jazayeri, MD1, Hirbod Nasiri Bonaki, MD1,
Alexander R. Vaccaro, MD, PhD, MBA2,
and Vafa Rahimi-Movaghar, MD1
Abstract
Study Design: Narrative review.
Objectives: Anterior cervical discectomy and fusion (ACDF) is a reliable procedure, commonly used for cervical degenerative
disc disease. For interbody fusions, autograft was the gold standard for decades; however, limited availability and donor site
morbidities have led to a constant search for new materials. Clinically, it has been shown that calcium phosphate ceramics,
including hydroxyapatite (HA) and tricalcium phosphate (TCP), are effective as osteoconductive materials and bone grafts. In this
review, we present the current findings regarding the use of ceramics in ACDF.
Methods: A review of the relevant literature examining the clinical use of ceramics in anterior cervical discectomy and fusion
procedures was conducted using PubMed, OVID and Cochrane.
Result: HA, coralline HA, sandwiched HA, TCP, and biphasic calcium phosphate ceramics were used in combination with
osteoinductive materials such as bone marrow aspirate and various cages composed of poly-ether-ether-ketone (PEEK), fiber
carbon, and titanium. Stand-alone ceramic spacers have been associated with fracture and cracks. Metallic cages such as titanium
endure the risk of subsidence and migration. PEEK cages in combination with ceramics were shown to be a suitable substitute for
autograft.
Conclusion: None of the discussed options has demonstrated clear superiority over others, although direct comparisons are
often difficult due to discrepancies in data collection and study methodologies. Future randomized clinical trials are warranted
before definitive conclusions can be drawn.
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Introduction
Anterior cervical discectomy and fusion (ACDF) is a reliable
and well-accepted procedure, commonly used for cervical
degenerative disc disease. Since its introduction in the 1950s
by Smith and Robinson,1 and later by Cloward,2 different graft
materials including autograft, allograft and bone substitute
have been used for the fusion. For decades, autograft (mostly
harvested from the iliac crest) was the most commonly used
material and the gold standard, owing to high fusion rate,
good biocompatibility, and nonimmunogenicity.3,4 However,
limited availability and donor site morbidities such as
pain, hematoma, infection, fracture, visceral herniation and
meralgia paresthetica, as well as increased blood loss and
operation time, have prompted surgeons to pursue new
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alternatives.5-9 Allograft (mostly freeze-dried graft made from
cadaveric bone) and xenograft (animal allograft) have been
used with satisfactory results, although pseudarthrosis,
immune-compatibility issues, and risk of infection with trans-
missible diseases remained concerning.10
Another alternative is development of synthetic bone graft
substitutes such as ceramics, poly-methyl-methacrylate
(PMMA) and biocompatible osteoconductive polymer (BOP).3
Ceramics are crystalline structures of mineral salts produced at
high temperature with various structural and physiological prop-
erties related to different processingmethods. The calcium phos-
phate ceramics, including hydroxyapatite (HA) and tricalcium
phosphate (TCP), are the most investigated bone substitutes and
have been used for nearly 30 years in dental and reconstructive
surgeries.11-17 Both HA and TCP are fragile materials, although
various preparation methods can yield a variety of compositions
ranging from amorphous porous to densely crystallized, which
consequently vary in compression strength and other proper-
ties.17,18 The porous structure resembles that of cancellous bone,
which enhances the ingrowth of host bone, while higher density
and crystallization produce a greater mechanical strength.17 Of
the fundamental properties of a bone graft (osteoconduction,
osteoinduction, and osteogenesis), ceramics provide osteocon-
duction, while the autograft is osteoconductive, osteoinductive,
and osteogenic, due to numerous surviving bone marrow
cells.16,19,20 Although there have been a growing number of clin-
ical studies investigating the application of ceramics in ACDF
during the past few years, the superiority of ceramic materials
over autograft is not definitive. The purpose of this article is to
review the clinical evidence on application of ceramics in ACDF
and to highlight the current state of the art.
Hydroxyapatite
HA [Ca10(PO4)6(OH)2] is a hydroxyl compound of calcium
phosphate and is the main component of natural mineralized
bone. The synthetic form is highly crystalline, produced
through a high-temperature reaction and is similar to the natu-
ral HA chemically and crystallographically. Such chemical
similarity to natural bone and the subsequent biocompatibility
and osteoconductivity is the exceptional property of HA.19,21
Formation of direct chemical bonding between the bone and
HA has been demonstrated by electron microscopy.22 Also, the
newly formed bone at the surface of the ceramic was similar to
normal bone, confirming the osteoconductivity of HA.22
Unlike autograft, allograft and TCP, the absorption rate of
HA is very low and with progression of the osteoconduction,
the newly produced bone encompasses the implant. Even
though the implant eventually fuses with the adjacent vertebrae
without absorption, it generally does not provoke foreign body
reaction.22,23 However, there is limited evidence of foreign
body reaction to the HA implants in cervical discectomy.24,25
Since the first clinical use of HA in ACDF by Koyama and
Handa26 in 1986, its utility has been evaluated in many studies.
In general clinical results were promising, demonstrating
that the graft was generally stable and formation of bridging
bone was observed without noticeable inflammatory reac-
tions.8,9,27-29 Senter et al8 used synthetic, dense, non-
resorptive HA spacers on 84 patients (Supplemental Table S1).
In their study, although the HA spacer was similar to iliac crest
autograft in terms of symptom relief, spinal alignment and
stability, superiority was demonstrated in terms of long-term
relief of symptoms, lower need for reoperation and the absence
of resorption with subsequent collapsed disc space.8 Kim et al9
used a 30% porous HA spacer with convex top and bottom
surfaces and a double pore structure (smaller pores of 2-5 mm
and larger pores 200-500 mm in diameter). They reported
equivalent improvements in neurological status, 100% graft
stability, formation of bridging bone 1 to 2 years after surgery,
no collapse of the vertebral body, and preserved normal cervi-
cal lordosis in most cases.9 In another study the same authors
used a rectangular HA spacer with a threaded design combined
with rigid anterior cervical spine plating. Complete fusion was
achieved in all cases and no graft extrusion, deterioration, sub-
sidence, or fracture was observed. Improvements in clinical
outcomes, formation of bridging bone on the surface of the
grafts in all patients, and preserved intervertebral space were
reported.27 Suetsuna et al28 used an open-pore structure HA
implant (100-500 mm), with 40% to 45% porosity in 36
patients. This open-pore structure preserves the continuity
between pores, which is conductive to tissue ingrowth and
enhances the access of living cellular constituents into the
implant; therefore, it is postulated that open-porosity improves
the regeneration processes.30,31 The authors found that the
radiographic results were not inferior to those of the same
procedure using autologous bone graft and no collapse or dis-
placement was observed.28 HA grafts with plate fixation were
used by Bruneau et al32 in 54 patients and demonstrated satis-
factory clinical and radiological results with 99% fusion rate
after a mean follow-up of 14.9 months. In their series, no
pseudarthrosis or dislocation was detected. There was graft
collapse or fracture in 4 of 68 fused levels which had no effect
on the fusion or clinical outcome.32 In the study by Vukic´
et al,29 HA graft was used in 86 patients with or without plat-
ing. The clinical outcome was good or excellent in 94% of
patients with radiculopathy, while it was less favorable in mye-
lopathic patients, of whom 54% had poor or fair results. No
graft collapse was detected and newly formed bone deposits,
which could enlarge over time and make a complete bony
bridge between the 2 endplates, were seen behind the graft in
all patients. However, 1-year fusion rates did not reach 100%
(86% for 2-level discectomy, 81% for 3-level discectomy, and
70% for 4-level discectomy). There were 8 graft fractures
which did not require surgery and 2 graft extrusions, which
occurred in noninstrumented patients and required revision
surgery.29
Although greater porosity of the HA enhances the osteocon-
ductivity and bony ingrowth, it is associated with more fragility
and fracture.33 To overcome this, Yoshii et al34 designed a new
synthetic HA block with a dense layer at the center for load
bearing covered by a porous layer, with 40% porosity and 100-
to 300-mm pores. To enhance osteoinduction and osteogenesis,
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the composite HA with small cancellous bone chips (trephine
bone) was used. Fifty-one patients underwent ACDF and ante-
rior plating. Fusion rates and preservation of the cervical lor-
dosis at 2-year follow-up were comparable in the HA and the
iliac crest autograft groups. No major collapse or fragmentation
of the HA graft occurred.34
ACDF with HA and metallic cages such as titanium has
been used based on satisfactory long-term outcomes of titanium
cages.35 Papavero et al36 used a rectangular fenestrated titanium
cage filled with a porous HA cylinder (porosity of 30%-80% and
mean pore diameter of 451 mm) soaked with vertebral bone
marrow aspirate (BMA) in 78 patients. Because the radio-
opaque implant limits the radiographic assessments, quantitative
computed tomography (qCT) was performed to evaluate the
graft. They did not detect any slippage or fracture and the HA
mass in the core of the implant increased up to 24%with a steady
state over 2 years, which supports coverage of the HA by a
newly formed bone layer. Seventy-one patients benefited from
the surgery with symptom alleviation and no revision surgery
was performed.36 Sugawara et al37 applied a cylindrical titanium
cage filled with HA granules (1-2 mm granules, 50% porosity) in
48 patients. The 2-year fusion rate was 90% and no material-
related adverse effects were observed.37
Unlike metallic cages, radiolucent materials such as poly-
ether-ether-ketone (PEEK) and carbon fiber–reinforced polymer
eliminate the difficulties of determining the degree of
fusion.20,38-41 In a clinical study on 45 patients, Chang et al20
compared the preliminary outcomes of cervical fusion using
PEEK cages containing either autologous bone or HA. During
2- to 10-year follow-up, they found no radiographic complica-
tions and the same fusion rate for both groups, suggesting that
ACDF with PEEK cage containing HA is a safe and suitable
alternative to autograft.20 Mashhadinezhad et al39 performed a
similar study on 236 patients. Improvement in neurological def-
icit, radicular pain, and recovery rate was the same between
PEEK cages filled with autograft and HA granules during 12-
month follow-up and no additional surgeries were required.39
During 54 to 90 months, Marotta et al38 followed 132 patients
who underwent ACDF with stand-alone carbon fiber cage filled
with HA and reported a significant improvement in clinical
evaluations. The fusion rate was 87.1%. Adjacent segment
degeneration was observed in 24 (18.1%) patients, of whom
13 (9.8%) required a new surgery.38 The term adjacent segment
degeneration (ASD) has been used to describe radiological
changes seen at levels adjacent to a previous spinal fusion site
that do not necessarily correlate with any clinical findings. In
contrast, “adjacent segment disease” is associated with new clin-
ical symptoms.42 It is postulated that the unique anatomy of the
cervical spine and a highly mobile upper cervical region make
this region vulnerable to ASD and after cervical fusion proce-
dures, the motion closely transfers to the upper cervical spine.42
Still, the risk factors directly correlated with ASD are not ade-
quately reported. Although it seems that the incidence of ASD is
lower in disc arthroplasty compared with fusion procedures such
as ACDF, the high-quality evidence so far have failed to demon-
strate a statistically significant difference.43,44
In a recent clinical trial, Yi et al45 implanted PEEK cages
filled with a mixture of HA/TCP or a mixture of HA/deminer-
alized bone matrix (DBM). One year after the operation, com-
plete bone fusion was achieved in 87% of patients in both
groups as demonstrated on dynamic radiographs. The fusion
rate on the CT scan was 87% for the HA/TCP mixture and 72%
for the HA/DBM mixture. Both groups were the same in terms
of clinical and radiological outcomes.45
Sandwiched Hydroxyapatite
In 1994, Isu et al46 modified an ACDF technique developed by
Williams, using bone grafts obtained from cervical vertebral
bodies (Williams-Isu method). Based on this, a sandwich
method was proposed by Suzuki et al47 in 1997 and a year later
by Takayasu et al,48 to be used when adequate amounts of bone
could not be harvested from the vertebral body. In this method,
HA is placed between 2 layers of the bone grafts. Kim et al49
conducted a radiological case-control study in 40 patients to
examine the efficacy of the sandwiched HA compared with the
Williams-Isu method. The alignment and height of the fused
segment were significantly better in the sandwich method. In
contrast, the whole spine alignment was the same.49 To facil-
itate the technique and eliminate the need for special equipment
such as a microsurgical saw and to decrease the risk of cervical
kyphosis in patients with preoperative kyphosis, Kogure et al50
modified the Williams-Isu method. They used a conventional
high-speed drill instead and reduced the size of the grafted
bone. Five patients underwent surgery and were followed for
3 years. Evaluations showed all patients had achieved solid
fusion. Two of the 4 patients with preoperative cervical kypho-
sis were free of kyphosis postoperatively.50
Coralline Hydroxyapatite
Sea coral is mainly composed of calcium carbonate. In a syn-
thetic process, all proteins are removed from the coral and the
calcium carbonate is converted to calcium HA. This method
preserves the geometric integrity of the biologic structure and
eliminates immunogenic proteins.51
In 1999, Thalgot et al51 used coralline HA implants with
rigid anterior plating in 26 patients. Although the authors could
not document the complete fusion by plain radiograph, all disc
spaces showed total incorporation at the end of 2-year follow-
up. Cracks were detected in four patients, without any evidence
of disc space collapse, plate migration or detrimental clinical
outcomes. Also, there were 2 plate migrations caused by falling
after surgery. The authors found the implant to be a promising
replacement for bone graft in the cervical spine.51 A prospec-
tive randomized trial was conducted by McConnell et al52 in 29
patients to compare coralline HA implants with conventional
iliac autograft. Although graft fragmentation and settling were
significantly higher in HA-implanted patients, the clinical out-
comes and final graft fusion rates were similar. The authors
were obligated to terminate further enrollment of participants
in the clinical trial due to the high percentage of fragmentation
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and collapse in the HA group. They concluded that the coral-
line HA implants did not possess adequate structural integrity
to resist axial loading during cervical interbody fusion.52 In
contrast, Mastronardi et al53 performed ACDF with PEEK
cages containing granulated coralline HA or a gel solution
composed of deantigenated pig bone. The fusion rate was
100% in both groups at 12-month follow-up and no major
complications such as breaking, collapse, angular deformation,
subsidence, or inflammatory reaction were noted.53
Tricalcium Phosphate
TCP [Ca3(PO4)2] is a bioabsorbable and biocompatible com-
pound that exists in either a or b crystalline forms.54 TCP is
more soluble and degradable than HA, with a higher bone
regeneration rate and lower mechanical strength.54-57
In 2009, Dai and Jiang55 evaluated the effectiveness of
interbody cages containing b-TCP for treatment of cervical
radiculopathy and myelopathy in a randomized clinical study
(Supplemental Table S2). Sixty-two patients received discect-
omy and fusion with interbody cages (carbon fiber or PEEK)
containing granulated b-TCP were randomly assigned to
receive plate fixation or not. At 3 months, the fusion rate in
patients without plating was significantly lower. However, suc-
cessful bony fusion was achieved in all patients across both
groups at 6-month follow-up assessment. Superior and/or infer-
ior cage immigration into the endplates was significantly
higher in patients without plating; yet there was no significant
difference in clinical improvement between 2 groups. No early
or late implant-related complications occurred and no addi-
tional surgeries were required. They found the b-TCP implant
with or without anterior plating an appropriate option for cer-
vical fusion.55
Acharya et al58 used stand-alone cervical cages filled with
b-TCP soaked in autologous bone marrow aspirate in 15
patients with a single-level cervical discopathy and followed
them for 12 months. At 6 months, 14 out of 15 patients had
bridging bony fusion on CT scan and the 1 patient who did not
have signs of union at 6 months, showed fusion at the final
follow-up. The clinical outcomes were excellent in 11 patients
and good or satisfactory in 4.58
In a study by Zagra et al,59 33 patients underwent implanta-
tion of a stand-alone PEEK cage augmented with b-TCP and
were compared with 2 other groups: (1) iliac autograft with
plate fixation and (2) iliac graft with titanium cage. All patients
achieved a solid fusion at the last follow-up. In patients treated
with PEEK cages and b-TCP no graft-related complications,
subsidence or migration of the cage was observed. In titanium
cage–implanted patients, subsidence and migration of the cage
into the vertebral body was observed in 7 patients (35%). The
authors proposed that the rigidity of titanium cages may pre-
dispose the implant to subsidence into the superior or inferior
adjacent vertebral body. The authors did not find any statistical
differences in clinical outcomes (pain and disability) at a min-
imum 5-year follow-up. Nevertheless, ACDF with PEEK cage
and b-TCP was not only clinically effective but also resulted in
a better fusion rate.59 Sugawara et al37 used cylindrical titanium
cages packed with b-TCP in 57 patients and found no disloca-
tion or material-related complications, in contrast to the study
by Zagra et al59 They reported that the fusion rate was signif-
icantly higher in the b-TCP compared with HA at 6-month
(46% vs 24%) and 1-year follow-up (69% vs 49%); however,
the fusion rate was similar between groups at 2-year follow-up
(94% vs 90%).37 Park and Roh60 compared the efficacy of iliac
autograft with PEEK cages filled with b-TCP. After 24 months,
fusion had occurred in 22 of 24 patients treated with b-TCP and
in 22 of 23 patients with iliac autograft. The fusion rate and
clinical outcomes of ACDF using PEEK cages filled with
b-TCP versus iliac autograft were similar; however, in patients
treated with PEEK cages and b-TCP the fusion was somewhat
delayed, there was more prevalent cage subsidence, and some
patients experienced segmental kyphosis.60
Two studies used a composite material containing b-TCP
and resorbable poly-L-lactic acid (PLLA) to produce an implant
that could endure high biomechanical stresses with lower risk
of rupture. Debusscher et al61 used a composite material with
45% porosity containing 60% b-TCP and 40% resorbable
PLLA to increase both strength and elasticity. The fusion rate
was 96% without mobility of the grafted levels for all patients
at 6 months after surgery. At a follow-up time beyond 36
months, complete resorption of cages was found only in
19%, while extensive (>50%) resorption was present in 48%
and partial (<50%) resorption in 33% of patients. Clinical out-
comes and the average overall and segmental lordotic angles
significantly improved over the follow-up period. No measur-
able implant displacement or other material complications,
cysts or lysis were detected on CT scan analysis at the last
follow-up.61 Brenke et al62 used a similar resorbable cage in
a larger group of patients with cervical disc degeneration (n ¼
33), but because of the observation of cage dislocations in 4
patients (2 dorsal and 2 ventral), the study was discontinued
prematurely. Postoperative radiographic morphology of the
cages showed changes within 3 months; 22 cages (71%) had
anterior and/or posterior eroded edges, 2 cages (6.7%) had a
central crack in the b-TCP core and 4 cages (13%) showed
signs of ventral or dorsal breakage of the composite part. The
authors concluded that the b-TCP/PLLA cage is inappropriate
for use as a stand-alone device due to unacceptably high rates
of implant dislocations.62
Biphasic Calcium Phosphate
Biphasic calcium phosphate (BCP) is a composite of HA,
which is less soluble, and b-TCP, which has greater
solubility.54,63 Thus the factor determining solubility in the
biphasic ceramics is the HA/b-TCP ratio; the lower the ratio,
the greater the solubility and osteoclastic resorption.63,64 How-
ever, osteoclastic resorption does not always enhance as solu-
bility increases. Yamada et al63 demonstrated that, although
pure b-TCP had the highest solubility in acidic solution, a
biphasic ceramic calcium with HA/b-TCP ratio of 25/75 was
more extensively resorbed with osteoclasts than pure b-TCP.
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In the clinical setting, the biphasic ceramic used for ACDF
is commonly composed of 60% HA and 40% b-TCP.65-67 The
study by Cho et al65 involving 100 patients showed that PEEK
cages containing BCP or autograft had 100% fusion rate at
6-month follow-up (Supplemental Table S3). Of note, the
fusion rate was lower with cages containing BCP than autograft
during the first 5 months after the operation. Spinal curve cor-
rection, neuroforamen enlargement, and neurological recovery
were the same in both groups.65 Chou et al66 compared the
results of BCP implants (9 with PEEK and 27 with titanium
cages) with autograft (n¼ 19). After 1 year, the fusion rate was
100% in patients treated with PEEK cages or autograft and no
subsidence or subluxation was reported in either, while the
titanium cage fusion rate was as low as 46.5% and led to sub-
sidence and subluxation in 26% and 3.7% of patients, respec-
tively. The PEEK cage containing BCP was demonstrated to be
a viable alternative to autograft.66 Another study using PEEK
cages containing BCP was conducted by Mobbs et al67 involv-
ing 58 patients. They reported that the fusion rate was 100% at
6 months with anterior plating and 96.2% without plate fixa-
tion. In the nonplated group, delayed fusion, nonunion, graft
subsidence, and graft migration occurred.67
Conclusion
This review was intended to discuss the current status of the use
of ceramic materials in ACDF procedures. Many options are
available including HA, coralline HA, sandwiched HA, TCP,
BCP, as well osteoinductive materials such as BMA and var-
ious cages composed of PEEK, fiber carbon, and titanium.
None of these options has demonstrated clear superiority over
others, although direct comparisons are often difficult due to
discrepancies in data collection and study methodologies.
Stand-alone ceramic spacers have been associated with fracture
and cracks. Metallic cages such as titanium endure the risk of
subsidence and migration. PEEK cages in combination with
ceramics were shown to be a suitable substitute for autograft.
PEEK is radiolucent, more elastic and has better capacity for
load distribution between the cage and bone; also, when filled
with ceramics, the spacer is osteoconductive. Plate fixation was
shown to be beneficial due to the lower risk of subsidence and
migration and possibly earlier fusion. However, more accurate
evaluations concerning the higher complication rate is
necessary.
The relative dearth of high-quality evidence in this arena
hinders decision making and the diversity of assessments in
different studies makes comparisons difficult. Traditionally,
the most widely accepted prognostic factor in ACDF has been
fusion status which was evaluated with various methods and
radiological modalities. Patient-related outcomes, which are
considered to be of critical importance, are neglected in some
studies. More homogeneity in the assessments and data presen-
tation is necessary for a good body of evidence. Future rando-
mized clinical trials are warranted before definitive
conclusions can be drawn.
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